Literature DB >> 29482748

[18F]-2-Fluoro-2-Deoxy-D-glucose-PET Assessment of Cervical Cancer.

Chitra Viswanathan1, Silvana Faria2, Catherine Devine2, Madhavi Patnana2, Tara Sagebiel2, Revathy B Iyer2, Priya R Bhosale2.   

Abstract

This article provides an overview of PET in cervical cancer, primarily with regard to the use of 18F-2-fluoro-2-deoxy-d-glucose-PET/computed tomography. A brief discussion of upcoming technologies, such as PET/MR imaging, is presented.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer staging; Cervical cancer; PET/CT; PET/MR imaging; Treatment planning

Mesh：

Substances：

Year:  2018        PMID： 29482748      PMCID： PMC5996999          DOI： 10.1016/j.cpet.2017.11.004

Source DB:  PubMed          Journal:  PET Clin        ISSN： 1556-8598


  57 in total

1.  Detection of early recurrence with 18F-FDG PET in patients with cervical cancer.

Authors:  Sang-Young Ryu; Moon-Hong Kim; Suck-Chul Choi; Chang-Woon Choi; Kyung-Hee Lee
Journal:  J Nucl Med       Date:  2003-03       Impact factor: 10.057

Review 2.  Update of the role of PET/CT and PET/MRI in the management of patients with cervical cancer.

Authors:  Benjapa Khiewvan; Drew A Torigian; Sahra Emamzadehfard; Koosha Paydary; Ali Salavati; Sina Houshmand; Sara Pourhassan Shamchi; Thomas J Werner; Aysel Aydin; Shambo Guha Roy; Abass Alavi; Rakesh Kumar
Journal:  Hell J Nucl Med       Date:  2016-11-08       Impact factor: 1.102

3.  Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  C Marth; F Landoni; S Mahner; M McCormack; A Gonzalez-Martin; N Colombo
Journal:  Ann Oncol       Date:  2017-07-01       Impact factor: 32.976

4.  Performance measurements of the Siemens mMR integrated whole-body PET/MR scanner.

Authors:  Gaspar Delso; Sebastian Fürst; Björn Jakoby; Ralf Ladebeck; Carl Ganter; Stephan G Nekolla; Markus Schwaiger; Sibylle I Ziegler
Journal:  J Nucl Med       Date:  2011-11-11       Impact factor: 10.057

5.  ACR Appropriateness Criteria® pretreatment planning of invasive cancer of the cervix.

Authors:  Cary Lynn Siegel; Rochelle F Andreotti; Higinia Rosa Cardenes; Douglas L Brown; David K Gaffney; Neil S Horowitz; Marcia C Javitt; Susanna I Lee; Donald G Mitchell; David H Moore; Gautam G Rao; Henry D Royal; William Small; Mahesh A Varia; Catheryn M Yashar
Journal:  J Am Coll Radiol       Date:  2012-06       Impact factor: 5.532

6.  Lymph node staging by positron emission tomography in patients with carcinoma of the cervix.

Authors:  P W Grigsby; B A Siegel; F Dehdashti
Journal:  J Clin Oncol       Date:  2001-09-01       Impact factor: 44.544

7.  Changes in cervical cancer FDG uptake during chemoradiation and association with response.

Authors:  Elizabeth A Kidd; Maria Thomas; Barry A Siegel; Farrokh Dehdashti; Perry W Grigsby
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-04-18       Impact factor: 7.038

8.  Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis.

Authors:  Elizabeth A Kidd; Barry A Siegel; Farrokh Dehdashti; Janet S Rader; David G Mutch; Matthew A Powell; Perry W Grigsby
Journal:  J Clin Oncol       Date:  2010-03-22       Impact factor: 44.544

9.  Usefulness of F-18 FDG PET/CT in Assessment of Recurrence of Cervical Cancer After Treatment.

Authors:  Minkyung Lee; Yukyung Lee; Kyung Hoon Hwang; Wonsick Choe; Chan Yong Park
Journal:  Nucl Med Mol Imaging       Date:  2011-01-28

10.  The role of [(18)F]FDG-PET/CT in staging and treatment planning for volumetric modulated Rapidarc radiotherapy in cervical cancer: experience of the European Institute of Oncology, Milan, Italy.

Authors:  Roberta Lazzari; Agnese Cecconi; Barbara A Jereczek-Fossa; Laura Lavinia Travaini; Veronica Dell' Acqua; Federica Cattani; Stefania Rizzo; Cristiana Fodor; Fabio Landoni; Roberto Orecchia
Journal:  Ecancermedicalscience       Date:  2014-03-05
View more
  4 in total

1.  Clinical perspectives for the use of total body PET/CT.

Authors:  Ronan Abgral; David Bourhis; Pierre-Yves Salaun
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-06       Impact factor: 9.236

2.  An Exploratory Study of Neoadjuvant Cetuximab Followed by Cetuximab and Chemoradiotherapy in Women With Newly Diagnosed Locally Advanced Cervical Cancer.

Authors:  Paula M Fracasso; Linda R Duska; Premal H Thaker; Feng Gao; Imran Zoberi; Farrokh Dehdashti; Barry A Siegel; Livnat Uliel; Christine O Menias; Patrice K Rehm; Sherry A Goodner; Allison N Creekmore; Heather L Lothamer; Janet S Rader
Journal:  Am J Clin Oncol       Date:  2022-06-07       Impact factor: 2.787

3.  Cervical cancer evaluated with integrated 18F-FDG PET/MR.

Authors:  Jing Gong; Nan Wang; Lihua Bian; Min Wang; Mingxia Ye; Na Wen; Meng Fu; Wensheng Fan; Yuanguang Meng
Journal:  Oncol Lett       Date:  2019-06-21       Impact factor: 2.967

Review 4.  2-Deoxy-d-Glucose and Its Analogs: From Diagnostic to Therapeutic Agents.

Authors:  B Pajak; E Siwiak; M Sołtyka; A Priebe; R Zieliński; I Fokt; M Ziemniak; A Jaśkiewicz; R Borowski; T Domoradzki; W Priebe
Journal:  Int J Mol Sci       Date:  2019-12-29       Impact factor: 5.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.